首页> 外文期刊>Journal of Chemistry >HPLC Method Development and Validation for Simultaneous Analysis of Diclofenac Sodium and Rabeprazole Sodium
【24h】

HPLC Method Development and Validation for Simultaneous Analysis of Diclofenac Sodium and Rabeprazole Sodium

机译:双氯芬酸钠和拉比普唑钠同时分析的HPLC方法的开发及验证

获取原文
           

摘要

A stable, simple, rapid, precise, accurate RP-HPLC method for simultaneous analysis of diclofenac sodium and rabeprazole sodium was developed and validated as per ICH guidelines without need of any internal standard. Separation was carried out using C8 column with triethyl amine buffer (pH 5): acetonitrile (50:50 v/v) as mobile phase with flow rate 2 mL min-1. The detection was carried out at 284 nm. The parameters studied were retention time, linearity and range, accuracy, precision, detection limit, quantitation limit and bench top stability. The proposed method can be used for simultaneous estimation of diclofenac sodium and rabeprazole sodium in bulk drugs and pharmaceutical dosage forms.
机译:用于同时分析双氯芬酸钠和拉比布拉唑钠的稳定,简单,快速,精确,精确的RP-HPLC方法,并根据ICH指导验证,无需任何内标。使用C8柱用三乙基胺缓冲液(pH5)进行分离:乙腈(50:50V / V),为流动率,流速2mL MIN-1。检测在284nm处进行。研究的参数是保留时间,线性度和范围,精度,精度,检测限,定量限制和台式稳定性。所提出的方法可用于同时估计二氯芬酸钠和拉比普拉唑钠以散装药物和药物剂型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号